Max Healthcare and Ahluwalia Contracts Q2 results review
after close1 source ↓written by the desknot a recommendation
- Max Healthcare reported
- 23% YoY EBITDA growth
- 21% YoY sales growth
- posted revenue
- ₹11.8 billion
Max Healthcare reported 23% YoY EBITDA growth and 21% YoY sales growth, driven by hospital sales up 22%. Ahluwalia Contracts posted revenue of ₹11.8 billion, with EBITDA beating estimates by 44.4%. These results reflect strong execution despite challenges from the extended monsoon, potentially impacting market sentiment positively.
Not investment advice. For informational purposes only.